CIT GROUP INC Loan Restructuring, Trial Modifications, Amount
CIT GROUP INC reported Loan Restructuring, Trial Modifications, Amount of $100.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LoanRestructuringTrialModificationsAmount · last filed 2021-11-05
- CIT GROUP INC loan restructuring, trial modifications, amount for the quarter ending 2021-09-30 was -$400.00K, a 125.00% decline year-over-year.
- CIT GROUP INC loan restructuring, trial modifications, amount for the quarter ending 2021-06-30 was -$1.10M, a 375.00% decline year-over-year.
- CIT GROUP INC loan restructuring, trial modifications, amount for the quarter ending 2021-03-31 was $1.60M, a 6.67% increase year-over-year.
- CIT GROUP INC loan restructuring, trial modifications, amount for the quarter ending 2020-12-31 was $1.00M, a 54.55% decline year-over-year.
- CIT GROUP INC loan restructuring, trial modifications, amount for fiscal 2019 was $5.50M, a 30.95% increase from fiscal 2018.
- CIT GROUP INC loan restructuring, trial modifications, amount for fiscal 2018 was $4.20M, a 66.40% decline from fiscal 2017.
- CIT GROUP INC loan restructuring, trial modifications, amount for fiscal 2017 was $12.50M.
| Period end | Loan Restructuring, Trial Modifications, Amount 3 month | Loan Restructuring, Trial Modifications, Amount 6 month | Loan Restructuring, Trial Modifications, Amount 9 month | Loan Restructuring, Trial Modifications, Amount 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$1.50M derived: sum of 2 quarters · filed 2021-11-05 | $100.00K 10-Q · filed 2021-11-05 | $1.10M derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $500.00K 10-Q · filed 2021-07-30 | $1.50M derived: sum of 3 quarters · filed 2021-11-05 | $3.10M derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-03-31 | $1.60M 10-Q · filed 2021-04-30 | $2.60M derived: sum of 2 quarters · filed 2021-11-05 | $4.20M derived: sum of 3 quarters · filed 2021-11-05 | $4.60M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-12-31 | $1.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2021-11-05 | $2.60M derived: sum of 2 quarters · filed 2021-11-05 | $3.00M derived: sum of 3 quarters · filed 2021-11-05 | $4.50M 10-Q · filed 2021-11-05 |
| 2020-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $2.00M derived: sum of 2 quarters · filed 2020-10-30 | $3.50M 10-Q · filed 2020-10-30 | $5.70M derived: sum of 4 quarters · filed 2021-02-19 |
| 2020-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $1.90M 10-Q · filed 2020-07-31 | $4.10M derived: sum of 3 quarters · filed 2021-02-19 | |
| 2020-03-31 | $1.50M 10-Q · filed 2020-05-05 | $3.70M derived: sum of 2 quarters · filed 2021-02-19 | ||
| 2019-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $5.50M 10-K · filed 2021-02-19 | ||
| 2019-09-30 | $3.30M 10-Q · filed 2019-11-01 | |||
| 2018-12-31 | $4.20M 10-K · filed 2021-02-19 | |||
| 2017-12-31 | $12.50M 10-K · filed 2020-02-20 |